'Icahn school' presentation slideshows

T icagrelor W ith Asp I rin or A L one I n Hi GH -Risk Patients After Coronary In T ervention

T icagrelor W ith Asp I rin or A L one I n Hi GH -Risk Patients After Coronary In T ervention. Roxana Mehran, MD on behalf of the TWILIGHT Investigators Icahn School of Medicine at Mount Sinai, New York, NY. ClinicalTrials.gov Number: NCT02270242. Declaration of Interest.

442 views • 38 slides